Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

Guizhi Jia; Yan Wang; Chengjie Lin; Shihui Lai; Hongliang Dai; Zhiqian Wang; Luo Dai; Huizhao Su; Yanjie Song; Naiwen Zhang; Yukuan Feng; Bo Tang

doi:10.1186/s13046-023-02626-z

Journal of Experimental & Clinical Cancer Research (Mar 2023)

Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

Guizhi Jia,
Yan Wang,
Chengjie Lin,
Shihui Lai,
Hongliang Dai,
Zhiqian Wang,
Luo Dai,
Huizhao Su,
Yanjie Song,
Naiwen Zhang,
Yukuan Feng,
Bo Tang

Affiliations

Guizhi Jia: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University
Yan Wang: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University
Chengjie Lin: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University
Shihui Lai: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University
Hongliang Dai: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University
Zhiqian Wang: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University
Luo Dai: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University
Huizhao Su: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University
Yanjie Song: Department of Pancreatic Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer
Naiwen Zhang: Department of Pancreatic Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer
Yukuan Feng: Department of Pancreatic Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer
Bo Tang: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University

DOI: https://doi.org/10.1186/s13046-023-02626-z
Journal volume & issue: Vol. 42, no. 1
pp. 1 – 1

Abstract

Read online

This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-021-02090-7.

Published in Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966 (Online)
Publisher: BMC
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jeccr.biomedcentral.com/

About the journal